Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,385,137 papers from all fields of science
Search
Sign In
Create Free Account
SR 13668
Known as:
SR-13668
, SR13668
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Carbazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs.
A. Banerjee
,
Hao Shen
,
+5 authors
A. Lyubimov
Current Pharmaceutical Biotechnology
2013
Corpus ID: 24411505
Potency and activity of SR13668 in cancer prevention have been proven in several in vitro and in vivo cancer models. However, the…
Expand
2012
2012
Enhanced oral bioavailability of a cancer preventive agent (SR13668) by employing polymeric nanoparticles with high drug loading.
Hao Shen
,
A. Banerjee
,
+5 authors
Y. Liu
Journal of Pharmacy and Science
2012
Corpus ID: 10546062
SR13668 [2,10-Dicarbethoxy-6-methoxy-5,7-dihydro-indolo-(2,3-b)carbazole] has been proven effective in cancer prevention, but the…
Expand
2012
2012
Abstract 2902: Polymeric nanoparticles enhance the bioavailability of the chemopreventive compound SR13668 in beagle dogs
A. Banerjee
,
Hao Shen
,
+4 authors
A. Lyubimov
2012
Corpus ID: 71356482
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Chemopreventive compound SR13668 showed promising…
Expand
2011
2011
Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668
J. Reid
,
Chad A. Walden
,
+14 authors
P. Limburg
Cancer Prevention Research
2011
Corpus ID: 19262656
SR13668, an orally active Akt pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical studies. To…
Expand
2011
2011
Abstract 4483: SR13668, a selective 12-lipoxygenase inhibitor, suppresses tumor growth by modulating the Akt signaling pathway
L. Jong
,
W. Chao
,
C. Green
,
I. Kapetanovic
,
L. Sambucetti
,
Nathan Collins
2011
Corpus ID: 72618418
SR13668, an orally active cancer therapeutic agent, exhibits potent antitumor activity against various human cancer xenografts (e…
Expand
2011
2011
SR 13668 Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor
J. Reid
,
Chad A. Walden
,
+14 authors
P. Limburg
2011
Corpus ID: 53553617
SR13668, an orally active Akt pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical studies. To…
Expand
2010
2010
Abstract CN02-03: Phase 0 chemoprevention trial of SR13668, a novel AKT inhibitor, in normal volunteers
J. Reid
,
Chad A. Walden
,
+13 authors
P. Limburg
2010
Corpus ID: 74775803
Purpose: SR13668, an orally active AKT pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical…
Expand
2009
2009
In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes.
J. Jackson
,
K. Kabirov
,
I. Kapetanovic
,
A. Lyubimov
Chemico-Biological Interactions
2009
Corpus ID: 206481766
2006
2006
Signaling-transduction pathways required for ex vivo expansion of human limbal explants on intact amniotic membrane.
Hua He
,
Hee-Tae Cho
,
Wei Li
,
T. Kawakita
,
L. Jong
,
S. Tseng
Investigative Ophthalmology and Visual Science
2006
Corpus ID: 18536227
PURPOSE Ex vivo expansion of limbal epithelial progenitor cells on amniotic membrane (AM) without 3T3 fibroblasts is a new…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE